Tuesday, October 27, 2015

Turing Pharmaceuticals Facing NY Antitrust Inquiry In Wake Of 5,000 Percent Price Hike ß BakerHostetler Turing Pharmaceuticals is back in the news over its marketing and distribution of Daraprim, the anti-parasitic drug crucial for treating toxoplasmosis, which can

No comments: